![John Yu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John Yu
Directeur Général chez Kairos Pharma Ltd.
Profil
John S.
Yu founded ImmunoCellular Therapeutics Ltd.
in 1987, where he worked as Chairman, Secretary & Chief Scientific Officer from 1987 to 2015 and Kairos Pharma Ltd.
in 2013, where he is working as Chairman & Chief Executive Officer from 2013.
Dr. Yu also currently works at Cedars-Sinai Medical Center, as Director-Surgical Neuro Oncology from 1998 and Enviro Therapeutics, Inc., as Chief Financial Officer & Director from 2019.
Dr. Yu received his graduate degree in 1990 from Harvard University, undergraduate degree in 1985 from Stanford University, and doctorate degree in 1990 from Harvard Medical School.
Postes actifs de John Yu
Sociétés | Poste | Début |
---|---|---|
Kairos Pharma Ltd.
![]() Kairos Pharma Ltd. Pharmaceuticals: MajorHealth Technology Kairos Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of novel and transformative drug therapies to treat cancer. It focuses on the research and development of immunotherapies for oncology. The company was founded by John S. Yu on June 17, 2013 and is headquartered in Los Angeles, CA. | Directeur Général | 17/06/2013 |
Cedars-Sinai Medical Center
![]() Cedars-Sinai Medical Center Hospital/Nursing ManagementHealth Services Cedars-Sinai Medical Center operates a hospital that provides healthcare services. It specializes in cancer, endocrinology, gynecology, neurology, orthopedics, and respiratory disorders. The company was founded in 1902 and is headquartered in Los Angeles, CA. | Corporate Officer/Principal | 01/01/1998 |
Anciens postes connus de John Yu
Sociétés | Poste | Fin |
---|---|---|
EOM PHARMACEUTICALS HOLDINGS, INC. | Fondateur | - |
Formation de John Yu
Stanford University | Undergraduate Degree |
Harvard University | Graduate Degree |
Harvard Medical School | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 3 |
---|---|
ImmunoCellular Therapeutics Ltd.
![]() ImmunoCellular Therapeutics Ltd. BiotechnologyHealth Technology ImmunoCellular Therapeutics, Ltd. is a clinical-stage pharmaceutical company, focused on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also develops EOM 147, an investigational, broad-spectrum aminosterol with an intracellular mechanism for the treatment of chronic and debilitating retinal diseases. The company was founded on March 20, 1987 and is headquartered in Montvale, NJ. | Health Technology |
Kairos Pharma Ltd.
![]() Kairos Pharma Ltd. Pharmaceuticals: MajorHealth Technology Kairos Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of novel and transformative drug therapies to treat cancer. It focuses on the research and development of immunotherapies for oncology. The company was founded by John S. Yu on June 17, 2013 and is headquartered in Los Angeles, CA. | Health Technology |
Cedars-Sinai Medical Center
![]() Cedars-Sinai Medical Center Hospital/Nursing ManagementHealth Services Cedars-Sinai Medical Center operates a hospital that provides healthcare services. It specializes in cancer, endocrinology, gynecology, neurology, orthopedics, and respiratory disorders. The company was founded in 1902 and is headquartered in Los Angeles, CA. | Health Services |